Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic steroid users may face higher risk of severe COVID-19.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

ERG increases SOX9, promoting prostate cancer growth and invasion.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.